CORNERSTONE THERAPEUTICS INC Sales Allowances, Goods (Deprecated 2018-01-31)
CORNERSTONE THERAPEUTICS INC reported Sales Allowances, Goods (Deprecated 2018-01-31) of $23.09 million for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Notes
us-gaap:SalesAllowancesGoods · last filed 2013-11-07
- CORNERSTONE THERAPEUTICS INC sales allowances, goods (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $23.09M, a 13.93% increase year-over-year.
- CORNERSTONE THERAPEUTICS INC sales allowances, goods (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $18.53M, a 110.16% increase year-over-year.
- CORNERSTONE THERAPEUTICS INC sales allowances, goods (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $18.57M, a 54.41% increase year-over-year.
- CORNERSTONE THERAPEUTICS INC sales allowances, goods (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $19.91M, a 43.71% increase year-over-year.
- CORNERSTONE THERAPEUTICS INC sales allowances, goods (deprecated 2018-01-31) for fiscal 2012 was $61.02M, a 4.77% decline from fiscal 2011.
- CORNERSTONE THERAPEUTICS INC sales allowances, goods (deprecated 2018-01-31) for fiscal 2011 was $64.08M, a 0.05% decline from fiscal 2010.
- CORNERSTONE THERAPEUTICS INC sales allowances, goods (deprecated 2018-01-31) for fiscal 2010 was $64.11M.
| Period end | Sales Allowances, Goods (Deprecated 2018-01-31) 3 month | Sales Allowances, Goods (Deprecated 2018-01-31) 6 month | Sales Allowances, Goods (Deprecated 2018-01-31) 9 month | Sales Allowances, Goods (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2013-09-30 | $23.09M 10-Q · filed 2013-11-07 | $41.62M derived: sum of 2 quarters · filed 2013-11-07 | $60.20M 10-Q · filed 2013-11-07 | $80.11M derived: sum of 4 quarters · filed 2013-11-07 |
| 2013-06-30 | $18.53M 10-Q · filed 2013-08-06 | $37.10M 10-Q · filed 2013-08-06 | $57.01M derived: sum of 3 quarters · filed 2013-08-06 | $77.28M derived: sum of 4 quarters · filed 2013-11-07 |
| 2013-03-31 | $18.57M 10-Q · filed 2013-05-09 | $38.48M derived: sum of 2 quarters · filed 2013-05-09 | $58.75M derived: sum of 3 quarters · filed 2013-11-07 | $67.57M derived: sum of 4 quarters · filed 2013-11-07 |
| 2012-12-31 | $19.91M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $40.18M derived: sum of 2 quarters · filed 2013-11-07 | $48.99M derived: sum of 3 quarters · filed 2013-11-07 | $61.02M 10-K · filed 2013-03-14 |
| 2012-09-30 | $20.27M 10-Q · filed 2012-11-08 | $29.09M derived: sum of 2 quarters · filed 2013-11-07 | $41.11M 10-Q · filed 2013-11-07 | $54.97M derived: sum of 4 quarters · filed 2013-11-07 |
| 2012-06-30 | $8.82M 10-Q · filed 2013-08-06 | $20.85M 10-Q · filed 2013-08-06 | $34.70M derived: sum of 3 quarters · filed 2013-08-06 | $47.40M derived: sum of 4 quarters · filed 2013-08-06 |
| 2012-03-31 | $12.03M 10-Q · filed 2013-05-09 | $25.88M derived: sum of 2 quarters · filed 2013-05-09 | $38.58M derived: sum of 3 quarters · filed 2013-05-09 | $54.89M derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $13.85M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $26.55M derived: sum of 2 quarters · filed 2013-03-14 | $42.86M derived: sum of 3 quarters · filed 2013-03-14 | $64.08M 10-K · filed 2013-03-14 |
| 2011-09-30 | $12.70M 10-Q · filed 2012-11-08 | $29.01M derived: sum of 2 quarters · filed 2012-11-08 | $50.23M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $16.31M 10-Q · filed 2012-08-09 | $37.53M 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $64.11M 10-K · filed 2013-03-14 |